Alzecure Pharma Stock Beta
| ALZCUR Stock | SEK 1.80 0.09 4.76% |
AlzeCure Pharma fundamentals help investors to digest information that contributes to AlzeCure Pharma's financial success or failures. It also enables traders to predict the movement of AlzeCure Stock. The fundamental analysis module provides a way to measure AlzeCure Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzeCure Pharma stock.
AlzeCure |
AlzeCure Pharma Company Beta Analysis
AlzeCure Pharma's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current AlzeCure Pharma Beta | 0.76 |
Most of AlzeCure Pharma's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzeCure Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, AlzeCure Pharma has a Beta of 0.7575. This is 11.92% lower than that of the Healthcare sector and 54.91% lower than that of the Drug Manufacturers - Specialty & Generic industry. The beta for all Sweden stocks is notably lower than that of the firm.
AlzeCure Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AlzeCure Pharma's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AlzeCure Pharma could also be used in its relative valuation, which is a method of valuing AlzeCure Pharma by comparing valuation metrics of similar companies.AlzeCure Pharma is currently under evaluation in beta category among related companies.
As returns on the market increase, AlzeCure Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding AlzeCure Pharma is expected to be smaller as well.
AlzeCure Fundamentals
| Return On Equity | -1.55 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 173.51 M | |||
| Shares Outstanding | 59.19 M | |||
| Shares Owned By Insiders | 41.31 % | |||
| Shares Owned By Institutions | 6.48 % | |||
| Price To Book | 6.62 X | |||
| EBITDA | (77.2 M) | |||
| Net Income | (77.78 M) | |||
| Cash And Equivalents | 222.05 M | |||
| Cash Per Share | 5.88 X | |||
| Current Ratio | 48.05 X | |||
| Book Value Per Share | 0.63 X | |||
| Cash Flow From Operations | (70.64 M) | |||
| Earnings Per Share | (1.78) X | |||
| Target Price | 11.88 | |||
| Number Of Employees | 14 | |||
| Beta | 0.76 | |||
| Market Capitalization | 254.44 M | |||
| Total Asset | 45.65 M | |||
| Z Score | -3.3 | |||
| Net Asset | 45.65 M |
About AlzeCure Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzeCure Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzeCure Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzeCure Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AlzeCure Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AlzeCure Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against AlzeCure Stock
| 0.68 | IPCO | International Petroleum Earnings Call This Week | PairCorr |
| 0.68 | LOGI-A | Logistea A Earnings Call Tomorrow | PairCorr |
| 0.58 | LOGI-B | Logistea AB Series | PairCorr |
| 0.54 | SPRINT | Sprint Bioscience Earnings Call This Week | PairCorr |
| 0.41 | CIRCHE | CirChem AB | PairCorr |
The ability to find closely correlated positions to AlzeCure Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AlzeCure Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AlzeCure Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AlzeCure Pharma to buy it.
The correlation of AlzeCure Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AlzeCure Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AlzeCure Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AlzeCure Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AlzeCure Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |